HB 1235 Summary

• Moves pseudoephedrine from Schedule V to Schedule III of the Uniform Controlled Dangerous Substances Act, classifying it as a controlled substance with restrictions on possession and sales

• Eliminates previous regulations requiring pharmacist supervision, written logs, identification verification, and monthly purchase limits for over-the-counter pseudoephedrine products

• Requires dispensers of Schedule II-V controlled substances (including pseudoephedrine when prescribed) to report dispensation data to a central repository within 24 hours using electronic transmission

• Establishes confidentiality protections for the central repository database with access limited to law enforcement, federal DEA, state licensing boards, grand juries, and registrants for diversion investigations

• Takes effect November 1, 2011